Tag: psoriasis

Psoriatic Arthritis: Tips for Managing

Medical treatment for your psoriatic arthritis (PsA) is essential for managing symptoms and protecting your joints. But alongside therapies and regular checkups, there are daily...

New Analysis Puts US Psoriasis Prevalence at 3%

Psoriasis affects over 7.5 million adults in the United States, with prevalence nearly twice as high among Whites as non-Whites, according to an analysis of...

Biologic Treatment Mitigates PsA Risk in Patients With Psoriasis, Study Finds

Psoriasis patients treated with biological disease-modifying antirheumatic drugs had a significantly lower incidence of psoriatic arthritis (PsA) compared with those treated with phototherapy, in a...

Evaluation in Various Specialties Underway

Advances in photobiomodulation have propelled the use of therapeutic applications in a variety of medical specialties, according to Juanita J. Anders, PhD. Dr Juanita J....

Psoriasis and Body Image

Joni Kazantzis was 15 years old when she woke up one morning covered with red, scaly spots that looked a lot like chickenpox. It happened...

Are Psoriasis and Allergies Linked?

If you have psoriasis and allergies, maybe you’ve wondered if your allergy flares make your skin condition worse. There’s no need to guess: Doctors and...

Psoriasis Video Center

Transcript close Mike: My name is Mike. I have psoriasis and this is a day in my life. I had issues with my scalp and...

Study Finds Psoriasis Associated With an Increased COVID-19 Risk

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. People with psoriasis have a higher risk of infection with COVID-19...

New Drug May Be Better Psoriasis Treatment

By Dennis Thompson HealthDay Reporter MONDAY, April 26, 2021 (HealthDay News) — A breakthrough psoriasis drug is better at treating the itchy and painful skin...

Bimekizumab Tops Adalimumab for Plaque Psoriasis

Bimekizumab bested adalimumab for moderate to severe plaque psoriasis in a phase 3 trial of adults from the agent’s maker UCB Pharma. The interleukin-17A (IL-17A)...

Should Biologics Be Used for Milder Cases of Psoriasis?

The remarkable efficacy of biologics for moderate-to-severe psoriasis has led some to ask if biologics should be used for milder cases. The issue was tackled...

Psoriasis Clearance Rates Higher With Bimekizumab vs Secukinumab

Secukinumab is the latest adult plaque psoriasis treatment to be bested by a newcomer, the interleukin 17A and 17F blocker bimekizumab. Rates of complete clearance...

Study Enhances Understanding of Prurigo Nodularis

Patients with prurigo nodularis tend to make a greater number of visits to health care specialists and are burdened by a greater number of medical...

Psoriasis Pathophysiology Insights Carry Treatment Implications

Dr Kenneth Brian Gordon Several surprising recent insights into the pathophysiology of psoriasis may eventually lead to superior treatment strategies for this common T-cell-mediated disease,...

Hepatotoxicity Risk Differs Between Psoriasis, PsA, and RA Patients

Patients taking methotrexate for psoriasis or psoriatic arthritis (PsA) were at a higher risk of developing liver disease than were patients with rheumatoid arthritis (RA)...

Tildrakizumab for Psoriasis Shows Durable Efficacy Over 5 Years

The full 5-year results of a long-term extension study of tildrakizumab for psoriasis show a high rate of sustained disease control coupled with a favorable safety...

Topical Tapinarof Effective in Pivotal Psoriasis Trials

Tapinarof cream 1% applied once daily in patients with plaque psoriasis convincingly hit its primary and secondary endpoints and was well tolerated in two identical...

Mirikizumab Beats Placebo, Secukinumab for Psoriasis

The investigational monoclonal antibody mirikizumab performed more robustly against placebo overall — and the interleukin (IL)-17 inhibitor secukinumab at key endpoints — for treatment of...

Pregnancy Studies on Psoriasis, PsA Medications Pick Up

Christina Chambers, PhD, MPH, who runs the MotherToBaby Pregnancy Studies research center at the University of California, San Diego, has found most pregnant women to...

How to Relieve One of the Itchiest Vulvar Conditions

A three-step approach may help relieve itch in patients with lichen simplex chronicus, “one of the itchiest conditions that we ever see on the vulva,”...

Ustekinumab May Trigger Acute CV Events Early in Treatment

Initiating treatment with the interleukin-12/23p40–targeting monoclonal antibody ustekinumab may trigger early severe cardiovascular events (SCEs) in susceptible patients, according to a large French case-time-control analysis. Investigators...

Some Psoriasis Meds May Also Help Prevent Heart Disease

TUESDAY, Sept. 15, 2020 (HealthDay News) — Biologic therapy for the skin condition psoriasis may reduce patients’ risk of heart disease, new research suggests. ...

The Long Road to a PsA Prevention Trial

About one-third of all patients with psoriasis will develop psoriatic arthritis (PsA), a condition that comes with a host of vague symptoms and no definitive...

Tailoring Treatment for Psoriasis, PsA, and Pregnancy

With an average age of diagnosis of 28 years, and one of two incidence peaks occurring at 15-30 years, psoriasis affects many women in the...

COMMENTARY: Dermatologist First, Businessman Second: Life During COVID-19

What your doctor is reading on Medscape.com: APRIL 15, 2020 — Monday 8:00 AM. Standing in the Stop & Shop parking lot,...